Findings from a retrospective analysis show that montelukast prophylaxis significantly reduced rituximab infusion-related reactions, particularly among patients receiving treatment for oncology indications.
Sian Behrendt-McElroy, PharmD, MS
Advertisement
Articles by Sian Behrendt-McElroy, PharmD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
McKesson ideaShare 2026: Recapping Key Insights from Denver
2
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
3
McKesson ideaShare 2026: What Does It Take to Sustain a Rural Independent Pharmacy? Sandie Kueker, RPh, Explains
4
Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial
5